IFPMA On Universal Health Coverage day, the Director General of IFPMA (the International Federation of Pharmaceutical Manufacturers and Associations) explains UHC and how the biopharmaceutical industry is part of the solution. Our industry is much more than a supplier of medicines and vaccines and is increasingly pioneering new ways to overcome…
IFPMA Geneva, 4 December 2018 – David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly and Company, was elected new President of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) for a two-year term. He succeeds Ian C. Read, Chairman of the Board and Chief Executive Officer, Pfizer. The IFPMA…
Regulation In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), defines ‘fair pricing’, gives the IFPMA’s take on so-called “cost-plus” pricing models, and talks about access to medicine in developing markets. The innovative pharmaceutical industry seems to be under unprecedented pressure…
Global The past 5 decades have seen monumental strides in healthcare; from the discovery that aspirin prevents blood clotting to the eradication of smallpox. In this exclusive interview, Thomas Cueni, director general of the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) reflects on 50 years of innovation from the associations…
See our Cookie Privacy Policy Here
